Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

69 study records (showing up to 30 per record type)

• Registered trial NCT05594355 Phase 4 Not completed: Active Not Recruiting
  Effect of Treatment With EGb 761(r) on Blood Markers of Inflammation and Oxidative Stress in Patients With MCI
  Condition or outcome area: Mild Cognitive Impairment (MCI)
  2021-04-16 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · ClinicalTrials.gov
• Registered trial NCT05398874 Completed (results not assessed here)
  Clinical Efficacy of Ginkgo Biloba Extract in the Treatment of Knee Osteoarthritis
  Condition or outcome area: Knee Osteoarthritis
  2021-11-01 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · ClinicalTrials.gov
• Registered trial NCT00070161 Phase 2 Completed (results not assessed here)
  Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor
  Condition or outcome area: Brain and Central Nervous System Tumors|Radiation Toxicity
  2001-07-01 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT02882438 Phase 1 Not completed: Unknown
  Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis
  Condition or outcome area: Foot Infection Tinea Pedis
  2016-01 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00103012 Phase 4 Completed (results not assessed here)
  Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers
  Condition or outcome area: Healthy
  2005-01 · Subject: Song Guo Ju; 松果菊; Echinacea; Echinacea Purpurea · open the herb record · ClinicalTrials.gov
• Registered trial NCT00103012 Phase 4 Completed (results not assessed here)
  Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers
  Condition or outcome area: Healthy
  2005-01 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00103012 Phase 4 Completed (results not assessed here)
  Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers
  Condition or outcome area: Healthy
  2005-01 · Subject: Ren Shen; 人参; Ginseng ;Ginseng; Radix et Rhizoma Ginseng;Ginseng Radix et Rhizoma · open the herb record · ClinicalTrials.gov
• Registered trial NCT02604381 Phase 2 Completed (results not assessed here)
  A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee.
  Condition or outcome area: Osteoarthritis of the Knee
  2015-11 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00446485 Phase 4 Completed (results not assessed here)
  Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
  Condition or outcome area: Mild Cognitive Impairment|Cerebrovascular Insufficiency
  2007-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT01139281 Phase 2 Completed (results not assessed here)
  The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans
  Condition or outcome area: Ototoxicity|Hearing Loss
  2007-06 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00689858 Phase 1 Completed (results not assessed here)
  Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or Placebo
  Condition or outcome area: Healthy
  2007-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00034021 Phase 2 Completed (results not assessed here)
  Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
  Condition or outcome area: Hypoactive Sexual Desire Disorder|Sexual Dysfunctions, Psychological
  2002-06 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00029991 Phase 1 / Phase 2 Completed (results not assessed here)
  Extract of Ginkgo Biloba (EGB 761) and Vascular Function
  Condition or outcome area: Intermittent Claudication|Peripheral Vascular Disease
  2000-09 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00011063 Phase 1 Completed (results not assessed here)
  Effect of Ginkgo Biloba on Phenytoin Elimination
  Condition or outcome area: Healthy
  2001-02 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00672373 Phase 3 Completed (results not assessed here)
  Extract of Ginkgo Biloba and Tardive Dyskinesia
  Condition or outcome area: Tardive Dyskinesia|Schizophrenia
  2006-12 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00032474 Phase 1 / Phase 2 Completed (results not assessed here)
  Ginkgo Biloba Extract and the Insulin Resistance Syndrome
  Condition or outcome area: Type 2 Diabetes Mellitus
  2001-12 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT01246804 Phase 1 Completed (results not assessed here)
  The Influence of GINkGo Biloba on the Pharmacokinetics of the UGT Substrate raltEgraviR (GINGER)
  Condition or outcome area: HIV Infections|Depression|Mild Cognitive Impairment
  2010-11 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT02386852 Early_Phase 1 Completed (results not assessed here)
  Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity
  Condition or outcome area: Blood Pressure|Cognition
  2014-03 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT02386852 Early_Phase 1 Completed (results not assessed here)
  Ginseng and Ginkgo Biloba Effects on Cognition as Modulated by Cardiovascular Reactivity
  Condition or outcome area: Blood Pressure|Cognition
  2014-03 · Subject: Ren Shen; 人参; Ginseng ;Ginseng; Radix et Rhizoma Ginseng;Ginseng Radix et Rhizoma · open the herb record · ClinicalTrials.gov
• Registered trial NCT02425436 Phase 2 Completed (results not assessed here)
  Role of Ginkgo Biloba Extract in IUGR
  Condition or outcome area: Intrauterine Growth Restriction (IUGR)
  2014-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT04121728 Not completed: Active Not Recruiting
  Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
  Condition or outcome area: Subjective Cognitive Decline|Cognitive Performance|Functional Capacity|Age-related Cognitive Decline
  2019-09-09 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT04334564 Not completed: Unknown
  Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome
  Condition or outcome area: Primary Open Angle Glaucoma|Drug Effect
  2015-04-28 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT01046292 Phase 4 Completed (results not assessed here)
  Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI
  Condition or outcome area: Mild Cognitive Impairment
  2010-01 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT05258123 Completed (results not assessed here)
  Ginkgo Biloba Extract in the Treatment of Schizophrenia
  Condition or outcome area: Schizophrenia
  2017-05-15 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT05258123 Completed (results not assessed here)
  Ginkgo Biloba Extract in the Treatment of Schizophrenia
  Condition or outcome area: Schizophrenia
  2017-05-15 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · ClinicalTrials.gov
• Registered trial NCT00010803 Phase 3 Completed (results not assessed here)
  Ginkgo Biloba Prevention Trial in Older Individuals
  Condition or outcome area: Dementia|Alzheimer's Disease
  2000-10 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00251238 Phase 2 Completed (results not assessed here)
  Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon
  Condition or outcome area: Raynaud Disease
  2005-11 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT02376114 Phase 2 Completed (results not assessed here)
  Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma
  Condition or outcome area: Glaucoma, Open-Angle
  2011-08 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT00907062 Phase 1 Completed (results not assessed here)
  Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
  Condition or outcome area: Vitiligo Vulgaris
  2009-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Registered trial NCT01524380 Completed (results not assessed here)
  Ginkgo Biloba Extract for Schizophrenia
  Condition or outcome area: Schizophrenia
  2011-09 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf;Ginkgo Folium; Folium Ginkgo;Ginkgo Folium · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42023449589 Registered protocol, no results here: Review Ongoing
  Systematic evaluation of ginkgo biloba extract in the treatment of vascular dementia
  Condition or outcome area: Vascular dementia (VD) refers to a syndrome of central nervous system damage related to blood vessels, often caused by various cerebrovascular diseases. Its clinical manifestations include decreased intelligence and social life abilities, accompanied by changes in personality and emotions [1], which greatly endangers the mental health and quality of life of the elderly and increases the personal care burden on families and society.
  2023-08-10 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023423789 Registered protocol, no results here: Review Ongoing
  Ginkgo biloba leaf extract EGb 761® for the treatment of various diseases: An overview of systematic reviews
  Condition or outcome area: This overview will consider systematic reviews with or without meta-analyses describing oral EGb 761® intake for clinical reasons, as prevention, or for health promotion.
  2023-05-15 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023486259 Registered protocol, no results here: Review Ongoing
  Systematic review and network meta-analysis of Ginkgo biloba extract preparations for ischemic stroke
  Condition or outcome area: Globally, one third, or 17.9 million, of total annual deaths are attributable to cardiovascular disease (CVD). The incidence of cardiovascular disease has declined since the middle of the last century, but less so in women than in men. CVD, such as stroke, transient ischemic attack, and coronary heart disease, share common (traditional) risk factors, including hypertension, hyperglycemia, hyperlipidemia, hyperuricemia, and obesity. Western medicines, such as hypotensive, hypoglycemic, lipid-lowe
  2023-12-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023486234 Registered protocol, no results here: Review Ongoing
  Efficacy and Safety of Ginkgo biloba Extract Injections in Patients with Acute Ischemic Stroke Undergoing Intravenous Thrombolysis: A Systematic Review and Meta-Analysis
  Condition or outcome area: Acute Ischemic Stroke
  2023-12-05 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023485940 Registered protocol, no results here: Review Ongoing
  Efficacy and safety evaluation of Ginkgo biloba extract in the treatment of cerebral hemorrhage：A systematic review, meta-analysis
  Condition or outcome area: cerebral hemorrhage
  2023-12-03 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023474678 Registered protocol, no results here: Review Ongoing
  The effect of Ginkgo biloba extract combined with donepezil on patients with vascular dementia:A protocol for systematic review and meta-analysis
  Condition or outcome area: Vascular dementia is a vascular cognitive impairment, making it the second most common type of dementia after Alzheimer's disease. There are currently no uniform standards for dementia treatment. Common treatments include cholinesterase inhibitors (such as Donepezil, galantamine, and NMDA receptor antagonists such as Memantine), which have been shown to improve cognitive function and score higher on behavioral scales in patients to varying degrees. However, these drugs can produce a variety of a
  2023-10-31 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023455792 Registered protocol, no results here: Review Ongoing
  The efficacy and safety of Ginkgo biloba extract combined with ACEI/ARB on diabetic nephropathy: a systematic review and meta-analysis
  Condition or outcome area: Diabetic nephropathy is one of the most severe complications of diabetes and is a primary cause of chronic kidney disease and end-stage renal disease. It is characterized by hyperfiltration and albuminuria in the early phase which is followed by progressive renal function decline, renal tubular epithelial cell hypertrophy, and tubulointerstitial fibrosis. The consequences of diabetic nephropathy extend beyond the kidneys, escalating the chances of cardiovascular diseases, nerve damage, and visio
  2023-08-30 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023447270 Registered protocol, no results here: Review Ongoing
  An update systematic review and meta-analysis on the efficacy of tricyclic antidepressants (TCAs), modafinil, bupropion, buspirone, and ginkgo biloba extract in treating attention deficit hyperactivity disorder (ADHD)
  Condition or outcome area: Attention deficit hyperactivity disorder (ADHD).
  2023-07-31 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023435565 Registered protocol, no results here: Review Ongoing
  Systematic evaluation of ginkgo biloba extract in the treatment of vascular dementia
  Condition or outcome area: Vascular dementia (VD) refers to a syndrome of central nervous system damage related to blood vessels, often caused by various cerebrovascular diseases. Its clinical manifestations include decreased intelligence and social life abilities, accompanied by changes in personality and emotions [1], which greatly endangers the mental health and quality of life of the elderly and increases the personal care burden on families and society.
  2023-08-07 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42023423363 Registered protocol, no results here: Review Completed not published
  Systematic review, meta-analysis and sequential analysis of ginkgo biloba extract in the treatment of IPF
  Condition or outcome area: Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic interstitial lung disease characterized by extensive pulmonary remodeling caused by abnormal deposition of extracellular matrix [1]. The main clinical manifestations of IPF are dry cough, dyspnea, progressive deterioration, and decreased lung function. The etiology of IPF is still unclear, and it mainly occurs in middle-aged and elderly people. The incidence of IPF is (6.8-16.3) per 100 000, and there are about 40 000 new cases diagnosed
  2023-05-16 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42015023354 Registered protocol, no results here: Review Ongoing
  Comparative efficacy and safety of Huperzine A and Ginkgo biloba extract in patients with Alzheimer’s disease: a network meta-analysis of randomized controlled trials
  Condition or outcome area: Alzheimer disease
  2015-06-10 · Subject: (-)-huperzine a; (-)-Selagine; Huperzine A; 102518-79-6; Fordine; HuperzineA; 120786-18-7; C15H18N2O; (1R,9R)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one; (1R,9R,13Z)-1-Amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one · open the ingredient record
• Systematic review registration CRD42015023354 Registered protocol, no results here: Review Ongoing
  Comparative efficacy and safety of Huperzine A and Ginkgo biloba extract in patients with Alzheimer’s disease: a network meta-analysis of randomized controlled trials
  Condition or outcome area: Alzheimer disease
  2015-06-10 · Subject: Huperzine a; Huperzine A; (-)-huperzine A; 102518-79-6; (-)-huperazine A; Selagine; Huperzin A; L-huperzine A; (-)-Selagine; Hup A · open the ingredient record
• Systematic review registration CRD42015023354 Registered protocol, no results here: Review Ongoing
  Comparative efficacy and safety of Huperzine A and Ginkgo biloba extract in patients with Alzheimer’s disease: a network meta-analysis of randomized controlled trials
  Condition or outcome area: Alzheimer disease
  2015-06-10 · Subject: Huperzine; (+/-)-Huperzine A; 120786-18-7; Huperzine A; (+/-)-Huperazine A; Fordine; ( inverted exclamation markA)-Huperzine A; HuperzineA; Huperizine A; Huperzine-A · open the ingredient record
• Systematic review registration CRD42022378970 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: a meta-analysis of clinical trials
  Condition or outcome area: Alzheimer’s disease is a progressive and insidious neurodegenerative disease (Zhou, 2010) that is most common among the elderly. With economic development and advances in medical care, human life expectancy has significantly increased, leading to an increase in the prevalence of Alzheimer’s disease
  2022-12-13 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022375806 Registered protocol, no results here: Review Ongoing
  A systematic review and meta-analysis of ginkgo biloba extract as a treatment for idiopathic pulmonary fibrosis
  Condition or outcome area: There is no explanation for the cause of idiopathic pulmonary fibrosis (IPF), which is a chronic, progressive, fibrotic, interstitial lung disease.It is a sequela of severe cases of the novel coronavirus disease (COVID-19) in the 2019 global outbreak and has been recognized as a risk factor for severe COVID-19 disease. Its clinical manifestations are progressively worsening dyspnea, restrictive ventilatory dysfunction and gas exchange disorders, hypoxemia and eventually respiratory failure and d
  2022-11-25 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022374851 Registered protocol, no results here: Review Ongoing
  The effect of ginkgo biloba on glycemic control in adults
  Condition or outcome area: In this review the effect of gingko biloba on glycemic control will be studied.
  2022-12-26 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022363313 Registered protocol, no results here: Review Ongoing
  Chinese Herbal Medicine Ginkgo biloba Leaf Preparation for Ischemic Stroke: An Overview of Systematic Reviews and Meta-Analyses
  Condition or outcome area: Stroke is a leading cause of disability and death and has become a global public health burden. Ischemic stroke is the main subtype of stroke, with a proportion of more than 80%. Traditional Chinese medicine therapy has been widely used as a potential complementary therapy in China. For example, Ginkgo biloba leaf preparation (GBLP) is considered to be a possible effective drug for ischemic stroke.
  2022-10-08 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022346140 Registered protocol, no results here: Review Ongoing
  The role of the administration of ginkgo biloba extract in the functional status of patients recovering from an acute stroke
  Condition or outcome area: Cardiovascular; Neurology
  2022-09-20 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022332298 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of standardized ginkgo biloba extract as adjunctive therapy for cerebral hemorrhage: a systematic review and meta-analysis
  Condition or outcome area: Intracerebral hemorrhage (ICH) is a common acute cerebrovascular disease caused by Intracerebral hemorrhage (ICP) due to non-traumatic factors. With the development of population aging, its incidence is increasing year by year. ICH has the characteristics of rapid onset, rapid progression, high disability and mortality. Although active treatment is carried out, most of the surviving patients are left with varying degrees of neurological dysfunction, which seriously affects the quality of life of
  2022-05-23 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42022298443 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of Ginkgo biloba extract injection for ischemic stroke: an overview of systematic reviews and meta-analyses.
  Condition or outcome area: ischemic stroke; Ginkgo biloba extract injection; overview of systematic reviews
  2022-01-17 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42021262738 Registered protocol, no results here: Review Ongoing
  The efficacy of Ginkgo Biloba in dementia with neuropsychiatric features: a meta analysis.
  Condition or outcome area: The prevalence of dementia is increasing, but there are few effective drugs available. There are many clinical trials that attempt to use herbs or herbal extracts to improve cognition. Ginkgo biloba, one kind of plant extract, has been proved to be effective for dizziness. But the efficacy of this extract in dementia is not unclear, especially for those with neuropsychiatric features.
  2021-07-25 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42021258090 Registered protocol, no results here: Review Ongoing
  Ginkgo biloba for Alzheimer's Disease and amnestic mild cognitive impairment: a meta-ananlysis
  Condition or outcome area: Cognitive impairment or dementia is an irreversible disease, which seriously affects the physical and mental health of patients. At present, cholinesterase inhibitors and NMDA receptor antagonists are the main therapeutic drugs. Some traditional Chinese medicine seems to have certain effect.
  2021-06-30 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42021244209 Registered protocol, no results here: Review Ongoing
  The efficacy and safety of Ginkgo Biloba Dropping Pills in the treatment of coronary heart disease angina: a systematic review and meta-analysis
  Condition or outcome area: Systematic evaluation of the Ginkgo Biloba Dropping Pills on coronary heart disease complicated with heart failure patients
  2021-04-21 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020216812 Registered protocol, no results here: status not recorded
  Effects and safety of ginkgo biloba extract injection on the vascular vertigoa systematic review and meta-analysis
  Condition or outcome area: Effects and Safety in the treatment of Vascular vertigo
  Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020212425 Registered protocol, no results here: Review Ongoing
  Effects and Safety of Oral Preparation of Ginkgo biloba extract on the Vascular vertigo: A Systematic Review and Meta-Analysis
  Condition or outcome area: Treatment Effects and Safety in the Vascular vertigo
  2020-11-26 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020169406 Registered protocol, no results here: Ongoing
  Ginkgo biloba for tinnitus [Cochrane protocol]
  Condition or outcome area: The Cochrane ENT Group
  2020-02-14 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020168126 Registered protocol, no results here: Review Ongoing
  Effects of Ginkgo Biloba extract for vascular dementia in animal models: a systematic review and meta-analysis
  2020-06-03 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020166805 Registered protocol, no results here: Review Ongoing
  Efficacy and safety of Ginkgo biloba for patients with early diabetic nephropathy: a protocol for systematic review and meta-analysis
  Condition or outcome area: Patients with early diabetic nephropathy
  2020-07-10 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020156354 Registered protocol, no results here: Review Ongoing
  Are ginkgo biloba based drugs potentially inappropriate medication (PIM) for the elderly – a systematic review for the update of the Austrian PIM List
  Condition or outcome area: Ginkgo biloba based drugs are often prescribed to elderly patients with dementia, cognitive dysfunction or etc. It is unclear whether the harms associated with Ginkgo biloba based drug use like headache, diarrhea etc. and other adverse events outweigh the possible benefits of ginkgo intake.
  2020-04-28 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Systematic review registration CRD42020151309 Registered protocol, no results here: Review Ongoing
  Ginkgo biloba for Alzheimer's Disease and amnestic mild cognitive impairment: a meta-ananlysis
  Condition or outcome area: The prevalence of cognitive impairment is increasing, but there are few effective drugs available. There are many clinical trials that attempt to use herbs or herbal extracts to improve cognition. Ginkgo biloba, one kind of plant extract, has been proved to be effective for dizziness, although the efficacy of this extract for patients with cognitive impairment is not yet clear.
  2020-03-04 · Subject: Yin Xing Ye; 银杏叶; Ginkgo Leaf; Ginkgo Folium; Folium Ginkgo · open the herb record
• Publication PMID 36162256 Research model: Animal & Cell Experiment
  Isoginkgetin, a bioactive constituent from Ginkgo Biloba, protects against obesity-induced cardiomyopathy via enhancing Nrf2/ARE signaling
  Condition or outcome area: obesity; cardiomyopathy; cardiac dysfunction; Obesity-induced metabolic cardiomyopathy; heart failure; cardiac diastolic dysfunction; mitochondrial defects; obese; lipotoxicity
  Redox Biol · 2022 · Subject: Isoginkgetin; 548-19-6; iso-ginkgetin; 4',4'''-Dimethylamentoflavone; 8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one; CHEBI:79087; DTXSID00203271; 3''',8-Biflavone, 5,5'',7,7''-tetrahydroxy-4',4'''-dimethoxy-; 8-(5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl)-5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one; 8-[5-(5,7-dihydroxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one · open the ingredient record · DOI 10.1016/j.redox.2022.102485
• Publication PMID 33113504 Research model: Cell Experiment
  Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
  Condition or outcome area: ferroptosis; Ferroptosis; cancer; advanced and non-targetable non-small-cell lung cancer
  Phytomedicine · 2021 · Subject: Ginkgetin; 481-46-9; 7,4'-Dimethylamentoflavone; Amentoflavone 7,4'-dimethyl ether; CHEBI:5353; HY5EZW8269; 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)chromen-4-one; DTXSID70197416; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-(5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl)-2-(4-hydroxyphenyl)-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)- · open the ingredient record · DOI 10.1016/j.phymed.2020.153370
• Publication PMID 36091773 Research model: Others
  MiR-146b-5p/TRAF6 axis is essential for Ginkgo biloba L. extract GBE to attenuate LPS-induced neuroinflammation
  Condition or outcome area: Neuroinflammation; cerebral and peripheral blood circulation disorders; neurodegenerative diseases; tumor; Alzheimer's disease
  Front Pharmacol · 2022 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.3389/fphar.2022.978587
• Publication PMID 35631163 Research model: Clinical & Cell Experiment
  Ginkgo Biloba Leaf Extract Improves an Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer's Disease Patients
  Condition or outcome area: chronic inflammation; Alzheimer's disease
  Nutrients · 2022 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.3390/nu14102022
• Publication PMID 34805278 Research model: Animal Experiment
  Cardioprotective Properties of Ginkgo Biloba Extract 80 via the Activation of AKT/GSK3β/β-Catenin Signaling Pathway
  Condition or outcome area: myocardial infarction; acute myocardial infarction
  Front Mol Biosci · 2021 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.3389/fmolb.2021.771208
• Publication PMID 34520829 Research model: Animal Experiment
  Systemic and topical Ginkgo biloba leaf extract (Egb-761) ameliorated rat paw inflammation in comparison to dexamethasone
  Condition or outcome area: inflammatory disease conditions; carrageenan-induced rat paw edema; rat paw edema
  J Ethnopharmacol · 2021 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.1016/j.jep.2021.114619
• Publication PMID 33492645 Research model: Animal Experiment
  Ginkgo biloba Extract (GbE) Restores Serotonin and Leptin Receptor Levels and Plays an Antioxidative Role in the Hippocampus of Ovariectomized Rats
  Condition or outcome area: hippocampal disorders
  Mol Neurobiol · 2021 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.1007/s12035-021-02281-5
• Publication PMID 32015684 Research model: Clinical Experiment
  Ginkgo biloba extract attenuates the disruption of pro-and anti-inflammatory T-cell balance in peripheral blood of arsenicosis patients
  Condition or outcome area: Arsenicosis; arsenicosis
  Int J Biol Sci · 2020 · Subject: Bai Guo Shu Pi; 白果树皮; Ginkgo Bark; Ginkgo Biloba · open the herb record · DOI 10.7150/ijbs.39351
• Publication PMID 30472463 Research model: Animal & Cell Experiment
  Ginkgetin, a biflavone from Ginkgo biloba leaves, prevents adipogenesis through STAT5-mediated PPARγ and C/EBPα regulation
  Condition or outcome area: obesity
  Pharmacol Res · 2019 · Subject: Ginkgetin; 481-46-9; 7,4'-Dimethylamentoflavone; Amentoflavone 7,4'-dimethyl ether; CHEBI:5353; HY5EZW8269; 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)chromen-4-one; DTXSID70197416; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-(5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl)-2-(4-hydroxyphenyl)-; 4H-1-Benzopyran-4-one, 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxo-4H-1-benzopyran-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)- · open the ingredient record · DOI 10.1016/j.phrs.2018.11.027